Half-year Report
Life Settlement Assets PLC: Final Results
20 September 2024
Life Settlement Assets PLC
(the "Company" or "LSA")
Results for the Half Year ended 30 June 2024
LSA, a closed-ended investment trust company which invests in, and manages, portfolios of whole interests in life settlement policies issued by life insurance companies operating predominantly in the United States, is pleased to announce its results for the Half Year ended 30 June 2024.
The highlights of the year were as follows:
Net Asset Value
· USD 108.8 million, representing USD 2.26 per share.
Maturities
· Maturities totalling USD 15.7 million were declared - of these, USD 11.8 million were non-HIV policies, and USD 3.9 million were HIV policies.
Mutual Benefits Keep Policy Trust ("MBC") Action
· Portfolio structure simplified following the MBC acquisition, and the Company is now in the final stages of absorbing this acquisition.
Costs
· Ongoing charges ratio excluding policy servicing fees and legal costs of 3.2% of NAV.
· Ongoing focus on management of costs.
Dividends
· On 15 February 2024 LSA announced the declaration of a special dividend of 6.0209 cents per share, totalling approximately USD 3.0 million, which was paid to Shareholders on 15 March 2024.
Share buybacks
· Total of 1,685,069 shares bought back and cancelled in the period at a total cost of USD 2,954,943.
Post Balance Sheet Events
The Company has bought back and cancelled a further 1,699,801 shares at a total cost of USD 3,044,701 since the period end and at the date of this report there were 46,441,914 shares in issue.
On 28 August 2024 the Company received notification that funds amounting to USD 9.7 million had been received by the Company, comprising the first tranche of the MBC sale proceeds of USD 5.7 million and the return of overpaid premiums of USD 4.0 million. The impact of this refund was reflected in the 31 July 2024 Net Asset Value of USD 2.3338 released to the market on 16 September 2024.
Michael Baines, Chairman, commented:
The Board remains focused on monitoring the performance of the Company's policy portfolio, accurately assessing mortality risk, and actively managing its cost base against the background of inflationary pressures. These results demonstrate further progress in the execution of the Board's strategy, which will allow further consideration of additional opportunities to return value to Shareholders.
The Directors are pleased to attach the Company's results for the Half Year ended 30 June 2024.
Click on the following link, or paste it into your web browser, to view the associated PDF document:
http://www.rns-pdf.londonstockexchange.com/rns/9405E_1-2024-9-19.pdf
The results for the half year ended 30 June 2024 may also be downloaded from the Company's website at
https://www.lsaplc.com/investor-relations/annual-reports/
For further information contact:
Acheron Capital Limited (Investment Manager)
Jean-Michel Paul
020 7258 5990
Shore Capital (Financial Adviser and Broker)
Anita Ghanekar/Gillian Martin /Harry Davies-Ball
020 7408 4090
ISCA Administration Services Limited
Company Secretary
Tel: 01392 487056
DISCLAIMER
Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.
Notes to Editors
Life Settlement Assets PLC is a closed-ended investment trust company which invests in, and manages, portfolios of whole interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The Company seeks to generate long-term returns for investors by investing in the life settlement market. The Company aims to manage its investment in portfolios of life settlement products so that the realised value of the policy maturities exceeds the aggregate cost of acquiring the policies, ongoing premiums, management fees and other operational costs.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.